TALWIN (Pentazocine) 50mg - 10 tabs
- Manufacturer: KRKA
Fortral Tablets: white f-c tablet marked Fortral and Sterwin. Fortral Capsules: grey/yellow capsule marked FORTRAL 50. Fortral Injection: 1 mL, 2mL ampoules. Fortral Suppositories: suppositories
Fortral Tablets: Pentazocine hydrochloride 25 mg . Fortral Capsules: Pentazocine hydrochloride 50 mg . Fortral Injection: Pentazocine (as lactate) 30mg per mL. Fortral Suppositories: Pentazocine (as lactate) 50 mg . Fortral preparations are not prescribable on the NHS. Pentazocine must be prescribed generically.
Moderate to severe pain.
Fortral Tablets: 25 - 100 mg three to four hourly after meals. Fortral Capsules: 50 - 100 mg three to four hourly after meals. Fortral Injection: 30 - 60 mg by intramuscular, intravenous, or subcutaneous injection three to four hourly. Fortral Suppositories: 1 as required. Maximum 4 daily.
Fortral Tablets: Under 1 year, not recommended; 1 - 6 years, use injection; 6 - 12 years, 25 mg three to four hourly. Fortral Capsules: Use tablets or Fortral Injection: Under 1 year, not recommended; 1 - 12 years, maximum single dose 1 mg/kg body- weight by intramuscular, intravenous or subcutaneous injection or 0 .5 mg/kg body- weight intravenously. Fortral Suppositories: Not recommended.
Established respiratory depression especially in the presence of cyanosis and excessive bronchial secretion. Acute alcoholism, head injuries, conditions in which intracranial pressure is raised, acute bronchial asthma, in heart failure secondary to chronic lung disease. Known hypersensitivity to pentazocine.
Porphyria. Phaeochromocytoma, acute phase following myocardial infarction. Renal or hepatic impairment. Elderly. Local injection site reactions may occur with pentazocine injection. Patients who are prone to seizures, patients taking other opioids or who are opioid- dependent - treat with caution. Hypothyroidism, adrenocortical insufficiency, prostatic hypertrophy, inflammatory or obstructive bowel disorders, cholecystitis, pancreatitis or other unidentified abdominal pain. History of drug abuse. Dependence may occur - avoid abrupt withdrawal of pentazocine therapy. Pregnancy and lactation.
MAOIs, narcotics, alcohol.
Most commonly, lightheadedness, dizziness, nausea and vomiting, sedation and sweating.